PharmaShots | Incisive News in 3 Shots

Subscribe Now

~$1.75B

Gilead Holds an Exclusive Option to Acquire Pionyr Immunotherapeutics for ~$1.75B

Gilead Holds an Exclusive Option to Acquire Pionyr Immunotherapeutics for ~$1.75B

June 24, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us